Antiepileptics Audit
|
|
- Oswald Bridges
- 5 years ago
- Views:
Transcription
1 Antiepileptics Audit Dr Kate Marley Dr Lucy Potter Dr Melanie Brooks Dr Averil Fountain CNS Sue Croft External Reviewer: Dr A Nicolson Consultant Neurologist c
2 CURRENT GUIDANCE
3 4.1 GENERAL PRINCIPLES Anti-epileptic drugs should be considered in all patients with primary or secondary brain tumours who have a history of one or more seizures. The acute management of seizures includes maintaining the airway, emergency drug treatment and a reassessment of the anti-epileptic drugs prescribed. A prolonged seizure in a patient who is not in the terminal phase requires immediate emergency management, resuscitation and possible admission to hospital.
4 4.1 GENERAL PRINCIPLES A clear distinction should be made between anti-epileptic drugs for the control of seizures and corticosteroid medication for control of symptoms due to tumour oedema e.g. headaches / vomiting due to raised intracranial pressure or focal neurological signs. Increasing the dose of corticosteroid is not recommended for seizures in the absence of new neurological symptoms / signs or evidence of raised intracranial pressure. However, as seizures may increase cerebral oedema, patients who develop new seizures in spite of anti-epileptic drugs may need optimization of anti-oedema therapies before modifying antiepileptic drugs.
5 4.1 GENERAL PRINCIPLES In the terminal phase, the aim is to prevent and control seizures with the minimum of disruption for the patient. Midazolam or clonazepam may be given without the need for transfer to hospital. Corticosteroids can be discontinued in the terminal phase unless they are required for control of raised intra-cranial pressure e.g. headaches/vomiting or seizures.
6 Table 4.1 illustrates the World Health Organisation classification of seizures Table 4.1 International Classification of Seizures [Level 4] 1. Generalised (involving the entire cortex). Tonic-clonic seizures (grand mal). Absence seizures (petit mal). Myoclonic seizures. Atonic seizures. 2. Partial/focal (involves a localised area of brain). Note: May spread to involve the whole c cortex i.e. secondary generalisation. Simple (no effect on conscious level). Complex (interrupt consciousness to varying degree). Secondary generalised tonic-clonic seizures.
7 Guidelines Antiepileptic medication The ideal drug for controlling seizures in palliative care patients is not easy to establish due to the variety of metabolic interactions and potential side effects. [Level 4] There are a variety of anti-epileptic drugs available and Table 4.2 gives further details. The choice of drug will depend on the type of seizure. [Level 4]
8 Clinical assessment should be used to optimise the dose of the anti-epileptic drug with the minimum of side effects. Monotherapy should be used whenever possible. [Level 4] It has been considered appropriate to use only new antiepileptic drugs when the older drugs (e.g. carbamazepine, sodium valproate) have been unsuccessful, or where they are unsuitable due to contraindications or drug interactions. However, lamotrigine or carbamazepine are now considered first line therapy for partial onset epilepsy, and lamotrigine has the advantage of being better tolerated with few drug interactions. [Level 4]
9 Guidelines Clobazam and clonazepam can be used for myoclonic or generalised tonic-clonic seizures. They will be effective for short-term use but patients may develop tolerance to the anti-epileptic effects of the benzodiazepines. In addition, any benefit may diminish over time although this may not always be relevant in the palliative care setting. Despite the possibility of tolerance with benzodiazepines many patients do get a sustained response to drugs such as Clobazam. [Level 4]
10 The metabolism of dexamethasone is accelerated by carbamazepine and phenytoin which reduce the steroid effect. The metabolism of phenytoin can be either increased or decreased by dexamethasone so altering the anti-epileptic effect. When using these drug combinations it may be necessary to increase the dose of anti-epileptic and / or corticosteroid. Drug levels are useful for patients on phenytoin. Levels can be used to guide dose titration if seizures are poorly controlled or side effects become apparent. [Level 3]
11 4.2.2 Management of seizures An acute seizure may settle spontaneously. Intranasal, buccal or subcutaneous midazolam should be available for the control of prolonged or recurrent seizures. Alternatively, lorazepam 2mg-4mg can be given intravenously or subcutaneously. [Level 4] For more information on intranasal midazolam see Figure 4.1. If seizures continue despite above measures, consider transfer to hospital for emergency management. A secure airway should be established, oxygen should be administered, cardio- respiratory function should be assessed and intravenous access should be established. Administer diazepam 10mg-20mg rectally and repeat 15 min later if status continues to threaten. Alternatively, consider giving midazolam 10mg via the buccal route or intravenously.[level 4]
12 Guidelines Clusters of seizures (i.e. with recovery in between attacks) may respond to oral clobazam. Starting dose is 10mg per day and the usual maintenance dose is 10mg-20mg twice daily. The maximum dose is 30mg twice daily. This drug can be used for a short period if required e.g.. a few days. [Level 4]
13
14
15 4.2.3 Use of anti-epileptics in the terminal phase In the terminal phase convert oral anti-epileptics to a continuous subcutaneous infusion of midazolam 30mg- 60mg/24 hours. Clonazepam is an alternative and will require less volume. [Level 4] If seizures are not controlled with midazolam / clonazepam, consider a change to phenobarbital 200mg-600mg/24h via a continuous subcutaneous infusion. Phenobarbital can be mixed with sodium chloride 0.9% or water, although anecdotal evidence suggests that may get less site reactions with sodium chloride 0.9%. It is generally recommended that a separate syringe driver should be used because of the high c ph of the drug. [Level 4]
16 4.2.3 Use of anti-epileptics in the terminal phase Discontinue oral corticosteroids unless needed for control of symptoms due to raised intracranial pressure e.g.. headaches, vomiting, seizures. Dexamethasone may be administered by subcutaneous bolus injection (for doses <8mg daily) or by a CSCI. [Level 4]
17 Standards 1. For all patients with primary or secondary brain tumours, the following information should be documented in the case notes: 14 [Grade D] History of seizures including the frequency and type. Anti-epileptic drug(s) used and the dose(s).
18 Standards 2. The dose of corticosteroids should not be increased if seizures occur in the absence of new neurological symptoms / signs or evidence of raised intracranial pressure, unless the patient is also taking phenytoin or carbamazepine. [Grade D] 3. All patients with a history of seizures should have access to medication that can be given in the event of an episode of prolonged seizures. [Grade D]
19 Standards 4. If a patient is in the terminal phase, oral anti-epileptic drugs should be converted to midazolam / clonazepam via a continuous subcutaneous infusion. [(Grade D] 5. If a patient is in the terminal phase and unable to take oral medication, corticosteroids should be discontinued unless they are needed for control of symptoms related to raised intracranial pressure. If they are required, they can be given via the subcutaneous route. [Grade D]
20 LITERATURE REVIEW
21 Before we start AED= NOT By definition, all patients with brain tumour associated epilepsy suffer from PARTIAL-ONSET seizures
22 Anti-epileptic drugs: a guide for the non-neurologist Choice of Anti-epileptic drug (AED) is complex: Age Co-morbidity Other medication Possibility of pregnancy Patient s epilepsy classification When patients are nil by mouth: Try to use iv preparation where possible or NGT Beware Phenytoin suspension 90mg = 100mg tablet Anderson J; Moor C: Clinical Medicine: Vol 10, Number 1, February 2010, pp (5)
23 Anti-epileptic drugs: a guide for the non-neurologist Routine checking of AED levels not needed Consider when: 1 week following change of phenytoin dose Status epilepticus Following emergency initiation of iv phenytoin Beware of enzyme inducing drugs and interactions: May decrease levels of warfarin and digoxin Many antidepressants lower seizure threshold Antipsychotics antagonise many AEDs Erythromycin/clarithromycin may increase levels of some AEDs In the elderly may need to choose drugs with fewer side effects rather than most efficacious Anderson J; Moor C: Clinical Medicine: Vol 10, Number 1, February 2010, pp (5)
24 SANAD Study (Arm A) Aim was to assess efficacy of other drugs for partial onset seizures where carbamazepine would have been considered standard treatment Un-blinded RCT in hospital OPDs in UK Arm A 1721 pts. randomised to carbamazepine, lamotrigine, oxcarbazepine, or topiramate. Primary outcomes: time to treatment failure and time to 12 months remission Results: Lamotrigine sig better than carbamazepine for time to treatment failure outcomes and is a cost-effective alternative for partial onset seizures Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW. SANAD study of effectiveness of valproate, lamotrigine and topiramate for generalised and unclassifiable epilepsy: an un-blinded randomised controlled trial. Lancet 2007; 369:
25 NICE Guidance Offer carbamazepine or lamotrigine as first-line treatment to children, young people and adults with newly diagnosed focal seizures. [new 2012] Combination therapy (adjunctive or 'add-on' therapy) should only be considered when attempts at monotherapy with AEDs have not resulted in seizure freedom. If an AED has failed because of adverse effects or continued seizures, a second drug should be started (which may be an alternative first-line or second-line drug) and built up to an adequate or maximum tolerated dose and then the first drug should be tapered off slowly National Institute for Health and Clinical Excellence. Clinical guideline 137. NICE, 2012.
26 NICE Guidance Regular blood test monitoring in adults is not recommended as routine, and should be done only if clinically indicated Indications for monitoring of AED blood levels are: detection of non-adherence to the prescribed medication suspected toxicity adjustment of phenytoin dose management of pharmacokinetic interactions (for example, changes in bioavailability, changes in elimination, and co-medication with interacting drugs) specific clinical conditions, for example, status epilepticus, organ failure and certain situations in pregnancy National Institute for Health and Clinical Excellence. Clinical guideline 137. NICE, 2012.
27 NICE Guidance: Management of a Seizure in the Community Only prescribe buccal midazolam or rectal diazepam for use in the community for children, young people and adults who have had a previous episode of prolonged or serial convulsive seizures. [new 2012] Administer buccal midazolam as first-line treatment in children, young people and adults with prolonged or repeated seizures in the community. Administer rectal diazepam if preferred or if buccal midazolam is not available. If intravenous access is already established and resuscitation facilities are available, administer intravenous lorazepam National Institute for Health and Clinical Excellence. Clinical guideline 137. NICE, 2012.
28 SPECIFIC GUIDANCE FOR BRAIN TUMOURS
29 Seizure Prophylaxis in Brain Metastases Systematic review of studies on patients with brain metastases comparing anticonvulsant prophylaxis versus none Only 1 underpowered RCT Conclusion: there is a lack of clear and robust benefit from the routine prophylactic use of anticonvulsants Mikkelson T et al. The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology January 2010, Volume 96, Issue 1, pp
30 Cochrane Review of Seizure Prophylaxis in Brain Tumours 5 trials met inclusion criteria Different brain tumours with different seizure risks Phenobarbital, phenytoin and divalproex sodium did not prevent seizures in people with brain tumours who had been seizure-free before participation in the study No studies on the newer AEDs Clinical heterogeneity limits any claim of effectiveness or ineffectiveness of prophylaxis Need to be mindful of the risks of side effects Tremont-Lukats IW, Ratilal BO, Armstrong T, Gilbert MR. Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD
31 SEIZURES IN PALLIATIVE CARE CONTEXT
32 RAMPART Trial Rapid Anticonvulsant Medication Prior to Arrival Trial Randomized double-blind phase 3 non-inferiority clinical trial IM midazolam vs. IV lorazepam Children and adults requiring treatment for status epilepticus in the pre-hospital setting Given either 10mg IM midazolam followed by IV placebo or IM placebo followed by 4mg IV lorazepam Primary outcome termination of seizures prior to arrival at A&E. Secondary outcomes time from opening box and time from administration of meds to seizure termination Midazolam at least as effective as lorazepam (p<0.001) Silbergleit R, Durkalsk V, Lowenstein D, Conwi R, Pancioli A, Palesch Y, Barsan W, Intramuscular versus Intravenous Therapy for Prehospital Status Epilepticus. NEJM vol 366(7)
33 Palliative Care Adult Network Guidelines Useful drugs in syringe driver :- clonazepam 1-4 mg/24h CSCI midazolam mg/24h CSCI phenobarbital mg/24h CSCI Avoid using drugs that may increase cerebral irritability such as phenothiazines (e.g.. levomepromazine) if possible. Should not be necessary to replace oral steroids with SC in dying patients who are unconscious or semi-conscious Watson M, Lucas C, Hoy A, Back I, Armstrong P. Palliative Care Adult Network Guidelines 2011
34 Seizures At End of Life No data regarding the preferred drug. In this Italian paper IM phenobarbital was used in community pts. and IV levetiracetam in hospitalised pts. at end of life [Pace et al 2012] American paper: stop AED if pt. never had a seizure and manage any seizures that occur. Aim to convert to rectal preparation. Data on midazolam not available but they say 5mg/hr [Hendrikus et al 2000] Pace A, Andrea, Villani V, Di Lorenzo C, Guariglia L, Maschio M, Pompili A, Carapella C, Epilepsy in the end-of-life phase in patients with high-grade gliomas. Journal of Neuro-Oncology Online first. Doi: /s Hendrikus GJ, Krouwer MD, Jeanne L, Pallagi MD Graves NM. Management o seizures in Brain Tumor Patients at the End of Life J Pall Med (4)
35 Status Epilepticus in the Hospice Setting Problems specific to this setting: Cachexic frail patients with difficult iv access Not always appropriate to transfer to hospital Lack of monitoring facilities May need large doses of medications. May get toxicity from the medications Droney J, Hall E. Status Epilepticus in a Hospice Inpatient Setting. J pain sympt management 1 July 2008 (volume 36 issue 1 Pages )
36 Status Epilepticus in the Hospice Setting Benzodiazepines helpful as they enter cerebral tissues quickly. Durations of action: Diazepam < 2 hours Midazolam 3-4 hours Clonazepam 24 hours Lorazepam up to 72 hours Clonazepam use may be limited by sorption to driver giving set and precipitation Droney J, Hall E. Status Epilepticus in a Hospice Inpatient Setting. J pain sympt management 1 July 2008 (volume 36 issue 1 Pages )
37 Status Epilepticus in the Hospice Setting In refractory cases: Switch to different benzodiazepine May need drugs from 2 classes e.g.. midazolam and phenobarbitone May need to switch from SC to iv route May need to consider moving to acute setting depending on situation Droney J, Hall E. Status Epilepticus in a Hospice Inpatient Setting. J pain sympt management 1 July 2008 (volume 36 issue 1 Pages )
38 UPDATED STANDARDS AND GUIDELINES
39 4.1 GENERAL PRINCIPLES Anti-epileptic drugs should be considered in all patients with primary or secondary brain tumours who have a history of one or more seizures. Patients with seizures due to brain tumours by definition have partial-onset seizures. The acute management of seizures includes maintaining the airway, emergency drug treatment and a reassessment of the anti-epileptic drugs prescribed. A prolonged seizure in a patient who is not in the terminal phase requires immediate emergency management, resuscitation and possible admission to hospital.
40 4.1 GENERAL PRINCIPLES A clear distinction should be made between anti-epileptic drugs for the control of seizures and corticosteroid medication for control of symptoms due to tumour oedema e.g. headaches / vomiting due to raised intracranial pressure or focal neurological signs. Increasing the dose of corticosteroid is not recommended for seizures in the absence of new neurological symptoms / signs or evidence of raised intracranial pressure. However, as seizures may increase cerebral oedema, patients who develop new seizures in spite of anti-epileptic drugs may need optimization of anti-oedema therapies before modifying antiepileptic drugs.
41 4.1 GENERAL PRINCIPLES In the terminal phase, the aim is to prevent and control seizures with the minimum of disruption for the patient. Midazolam or clonazepam may be given without the need for transfer to hospital. Corticosteroids can be discontinued in the terminal phase unless they are required for control of raised intra-cranial pressure e.g. headaches/vomiting or seizures.
42 Table 4.1 illustrates the World Health Organisation classification of seizures Table 4.1 International Classification of Seizures [Level 4] 1. Generalised (involving the entire cortex). Tonic-clonic seizures (grand mal). Absence seizures (petit mal). Myoclonic seizures. Atonic seizures. 2. Partial/focal (involves a localised area of brain). Note: May spread to involve the whole c cortex i.e. secondary generalisation. Simple (no effect on conscious level). Complex (interrupt consciousness to varying degree). Secondary generalised tonic-clonic seizures.
43 Guidelines Antiepileptic medication The ideal drug for controlling seizures in palliative care patients is not easy to establish due to the variety of metabolic interactions and potential side effects. [Level 4] There are a variety of anti-epileptic drugs available and Table 4.2 gives further details. The choice of drug will depend on the type of seizure. [Level 4]
44 Guidelines Clinical assessment should be used to optimise the dose of the anti-epileptic drug with the minimum of side effects. Monotherapy should be used whenever possible. [Level 4] Lamotrigine or carbamazepine are now considered first line therapy for partial onset epilepsy, and lamotrigine has the advantage of being better tolerated with few drug interactions. This means that Lamotrigine or Carbamazepine will be the first choice foe seizures associated with brain tumours [Level 4]
45 Guidelines For generalised-onset seizures sodium valproate should be considered as the first line anti-epileptic medication. Routine, regular blood test monitoring of antiepileptic drug levels is not recommended as and should be done only if clinically indicated. Indications for monitoring of AED blood levels are: suspected toxicity Poorly controlled seizures 1 week following adjustment of phenytoin dose management of pharmacokinetic interactions Status epilepticus Organ failure
46 Guidelines Clobazam and clonazepam can be used as an adjunct for myoclonic or generalised tonic-clonic seizures. They will be effective for short-term use but patients may develop tolerance to the anti-epileptic effects of the benzodiazepines. In addition, any benefit may diminish over time although this may not always be relevant in the palliative care setting. Despite the possibility of tolerance with benzodiazepines many patients do get a sustained response to drugs such as Clobazam. [Level 4]
47 The metabolism of dexamethasone is accelerated by carbamazepine and phenytoin which reduce the steroid effect. The metabolism of phenytoin can be either increased or decreased by dexamethasone so altering the anti-epileptic effect. When using these drug combinations it may be necessary to increase the dose of anti-epileptic and / or corticosteroid. Drug levels may be helpful in this situation. [Level 3]
48 4.2.2 Management of seizures An acute seizure may settle spontaneously. Intranasal, buccal or subcutaneous midazolam should be available for the control of prolonged or recurrent seizures. Alternatively, lorazepam 2mg-4mg can be given intravenously or subcutaneously. [Level 4] For more information on intranasal midazolam see Figure 4.1. If seizures continue despite above measures, consider transfer to hospital for emergency management. A secure airway should be established, oxygen should be administered, cardio- respiratory function should be assessed and intravenous access should be established. Administer diazepam 10mg-20mg rectally and repeat 15 min later if status continues to threaten. Alternatively, consider giving midazolam 10mg via the buccal route or intravenously.[level 4]
49 Guidelines Clusters of seizures (i.e. with recovery in between attacks) may respond to oral clobazam. Starting dose is 10mg per day and the usual maintenance dose is 10mg-20mg twice daily. The maximum dose is 30mg twice daily. This drug can be used for a short period if required e.g. a few days. [Level 4]
50
51 4.2.3 Use of anti-epileptics in the terminal phase In the terminal phase convert oral anti-epileptics to a continuous subcutaneous infusion of midazolam 20mg- 60mg/24 hours. Clonazepam is an alternative and will require less volume. [Level 4] If seizures are not controlled with midazolam / clonazepam, consider a change to phenobarbital 200mg-600mg/24h via a continuous subcutaneous infusion. Phenobarbital can be mixed with sodium chloride 0.9% or water, although anecdotal evidence suggests that may get less site reactions with sodium chloride 0.9%. It is generally recommended that a separate syringe driver should be used because of the high ph of the drug. [Level 4]
52 4.2.3 Use of anti-epileptics in the terminal phase For patients with brain tumours: Discontinue oral corticosteroids unless needed for control of symptoms due to raised intracranial pressure e.g. headaches, vomiting, seizures. Dexamethasone may be administered by subcutaneous bolus injection (for doses 8mg daily) or by a CSCI. [Level 4]
53
54 Patient has seizure Ensure airway secure and administer oxygen if available Seizure may settle spontaneously If seizure does not settle within 5 minutes give rescue medication e.g. Buccal or IM midazolam 10mg or rectal diazepam 10-20mg or lorazepam 2-4mg iv or sub cut If seizure does not settle after 15mins give another dose of rescue medication. Consider transfer to hospital If patient to stay in hospice or at home consider a syringe driver with midazolam 30mg over 24 hours
55 Standards 1. For all patients with primary or secondary brain tumours, any history of seizures should be documented in the case notes: [Grade D] 2. For all patients with a history of seizures the following should be documented: Frequency and type of seizure Anti-epileptic drug(s) used and the dose(s) [Grade D].
56 Standards 3. All patients with a history of seizures should have access to medication that can be given in the event of an episode of prolonged seizures. [Grade D] 4. For patients with brain tumours the dose of corticosteroids should not be increased if seizures occur in the absence of new neurological symptoms / signs or evidence of raised intracranial pressure, unless the patient is also taking phenytoin or carbamazepine. [Grade D]
57 Standards 5. If a patient is in the terminal phase, oral anti-epileptic drugs should be converted to midazolam or clonazepam via a continuous subcutaneous infusion initially. [Grade D] 6. If a patient is in the terminal phase and unable to take oral medication, corticosteroids should be discontinued unless they are needed for control of symptoms related to raised intracranial pressure. [Grade D]
58
Antiepileptics Audit
Antiepileptics Audit Dr Kate Marley Dr Lucy Potter Dr Melanie Brooks Dr Averil Fountain CNS Sue Croft External Reviewer: Dr A Nicolson Consultant Neurologist c CURRENT GUIDANCE 4.1 GENERAL PRINCIPLES Anti-epileptic
More information4. GUIDELINES FOR THE USE OF ANTI- EPILEPTICS IN PALLIATIVE CARE
4. GUIDELINES FOR THE USE OF ANTI- EPILEPTICS IN PALLIATIVE CARE 4.1 GENERAL PRINCIPLES Anti-epileptic drugs should be considered in all patients with primary or secondary brain tumours who have a history
More informationIn our patients the cause of seizures can be broadly divided into structural and systemic causes.
Guidelines for the management of Seizures Amalgamation and update of previous policies 7 (Seizure guidelines, ND, 2015) and 9 (Status epilepticus, KJ, 2011) Seizures can occur in up to 15% of the Palliative
More informationEpilepsy and Epileptic Seizures
Epilepsy and Epileptic Seizures Petr Marusič Dpt. of Neurology Charles University, Second Faculty of Medicine Motol University Hospital Diagnosis Steps Differentiation of nonepileptic events Seizure classification
More informationUpdated advice for nurses who care for patients with epilepsy
NICE BULLETIN Updated advice for nurses who care for patients with epilepsy NICE provided the content for this booklet which is independent of any company or product advertised NICE BULLETIN Updated advice
More informationOn completion of this chapter you should be able to: list the most common types of childhood epilepsies and their symptoms
9 Epilepsy The incidence of epilepsy is highest in the first two decades of life. It falls after that only to rise again in late life. Epilepsy is one of the most common chronic neurological condition
More informationlevetiracetam 250,500,750 and 1000mg tablets and levetiracetam oral solution 100mg/1ml (Keppra ) (No. 397/07) UCB Pharma Ltd
Scottish Medicines Consortium Resubmission levetiracetam 250,500,750 and 1000mg tablets and levetiracetam oral solution 100mg/1ml (Keppra ) (No. 397/07) UCB Pharma Ltd 11 January 2008 The Scottish Medicines
More informationAPPENDIX K Pharmacological Management
1 2 3 4 APPENDIX K Pharmacological Management Table 1 AED options by seizure type Table 1 AED options by seizure type Seizure type First-line AEDs Adjunctive AEDs Generalised tonic clonic Lamotrigine Oxcarbazepine
More informationOutline. What is a seizure? What is epilepsy? Updates in Seizure Management Terminology, Triage & Treatment
Outline Updates in Seizure Management Terminology, Triage & Treatment Joseph Sullivan, MD! Terminology! Videos of different types of seizures! Diagnostic evaluation! Treatment options! Acute! Maintenance
More informationsurvey Parenteral anti-epileptics What is your experience? May July 2015
Parenteral anti-epileptics What is your experience? May July 2015 Number of responses = 99 1a) In patients with pre-existing epilepsy controlled by PO medication that are imminently dying (prognosis
More information1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER
1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER 1.1 GENERAL PRINCIPLES There are many causes of agitation in palliative care patients, which makes recommendations for treatment difficult.
More informationLieven Lagae Department of Paediatric Neurology Leuven University Leuven, Belgium. Management of acute seizure settings from infancy to adolescence
Lieven Lagae Department of Paediatric Neurology Leuven University Leuven, Belgium Management of acute seizure settings from infancy to adolescence Consequences of prolonged seizures Acute morbidity and
More informationSeizures in high-grade glioma patients:
Seizures in high-grade glioma patients: a serious challenge in the end of life phase JAF Koekkoek,* EM Sizoo,* TJ Postma, JJ Heimans, HRW Pasman, L Deliens, MJB Taphoorn and JC Reijneveld BMJ Support Palliat
More informationNonConvulsive Seizure
Sample Protocol #5: Management of status epilepticus and seizures in hospitalized patients nconvulsive Seizure Patient presents with alteration of consciousness unexplained by other etiologies AND suspicious
More informationNeuromuscular Disease(2) Epilepsy. Department of Pediatrics Soochow University Affiliated Children s Hospital
Neuromuscular Disease(2) Epilepsy Department of Pediatrics Soochow University Affiliated Children s Hospital Seizures (p130) Main contents: 1) Emphasize the clinical features of epileptic seizure and epilepsy.
More informationAnticonvulsants Antiseizure
Anticonvulsants Antiseizure Seizure disorders Head trauma Stroke Drugs (overdose, withdrawal) Brain tumor Encephalitis/ Meningitis High fever Hypoglycemia Hypocalcemia Hypoxia genetic factors Epileptic
More informationTreatment of epilepsy in adults
Treatment of epilepsy in adults Review 33 Treatment of epilepsy in adults S B Gunatilake 1, A Arasalingam 2 Sri Lanka Journal of Neurology, 2012, 1, 33-38 Case vignettes 1. A 60-year old patient with long
More informationCosting statement. Implementing NICE guidance. January NICE clinical guideline 137
The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care (partial update of NICE clinical guideline 20) Costing statement Implementing NICE guidance
More informationThe epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care
The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care Issued: January 2012 last modified: January 2015 guidance.nice.org.uk/cg137 NICE has
More informationPrescribing and Monitoring Anti-Epileptic Drugs
Prescribing and Monitoring Anti-Epileptic Drugs Mark Granner, MD Clinical Professor and Vice Chair for Clinical Programs Director, Iowa Comprehensive Epilepsy Program Department of Neurology University
More informationThe epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care
The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care Issued: January 2012 guidance.nice.org.uk/cg137 NHS Evidence has accredited the process
More informationManagement of the Fitting Child. Dr Mergan Naidoo
Management of the Fitting Child Dr Mergan Naidoo Seizures A seizure is a change in movement, attention or level of awareness that is sustained or repetitive and occurs as a result of abnormal neuronal
More informationManagement of Epilepsy in Primary Care and the Community. Carrie Burke, Epilepsy Specialist Nurse
Management of Epilepsy in Primary Care and the Community Carrie Burke, Epilepsy Specialist Nurse Epilepsy & Seizures Epilepsy is a common neurological disorder characterised by recurring seizures (NICE,
More informationLMMG New Medicine Recommendation
LMMG New Medicine Recommendation Oxcarbazepine (Trileptal ) for the treatment of epilepsy LMMG Recommendation: Amber 0: Oxcarbazepine (Trileptal ) is recommended for use as monotherapy or adjunctive therapy
More informationWHOLE LOTTA SHAKIN GOIN ON
WHOLE LOTTA SHAKIN GOIN ON ADAM M. YATES, MD FACEP ASSOCIATE CHIEF OF EMERGENCY SERVICES UPMC MERCY SEIZURE DEFINITIONS Partial(focal) only involves part of the brain General Involves entire brain Simple
More informationStatus Epilepticus: Implications Outside the Neuro-ICU
Status Epilepticus: Implications Outside the Neuro-ICU Jeffrey M Singh MD Critical Care and Neurocritical Care Toronto Western Hospital October 31 st, 2014 Disclosures I (unfortunately) have no disclosures
More information2018 American Academy of Neurology
Practice Guideline Update Efficacy and Tolerability of the New Antiepileptic Drugs I: Treatment of New-Onset Epilepsy Report by: Guideline Development, Dissemination, and Implementation Subcommittee of
More informationStatus Epilepticus And Prolonged Seizures: Guideline For Management In Adults. Contents
Status Epilepticus And Prolonged Seizures: Guideline For Management In Adults Classification: Clinical guideline Lead Author: Rajiv Mohanraj, Consultant Neurologist Additional author(s): Matt Jones, Consultant
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Absence seizures, 6 in childhood, 95 Adults, seizures and status epilepticus in, management of, 34 35 with first-time seizures. See Seizure(s),
More informationReview of Anticonvulsant Medications: Traditional and Alternative Uses. Andrea Michel, PharmD, CACP
Review of Anticonvulsant Medications: Traditional and Alternative Uses Andrea Michel, PharmD, CACP Objectives Review epidemiology of epilepsy Classify types of seizures Discuss non-pharmacologic and pharmacologic
More informationContemporary Developments in Childhood Epilepsy Management. Olivia O Mahony, Cork University Hospital, Cork, and Mercy University Hospital
Contemporary Developments in Childhood Epilepsy Management Olivia O Mahony, Cork University Hospital, Cork, and Mercy University Hospital Developments in Epilepsy Care Standardised epilepsy care using
More informationClinical guideline Published: 11 January 2012 nice.org.uk/guidance/cg137
Epilepsies: diagnosis and management Clinical guideline Published: 11 January 2012 nice.org.uk/guidance/cg137 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationTalk outline. Some definitions. Emergency epilepsy now what? Recognising seizure types. Dr Richard Perry. Management of status epilepticus
Emergency epilepsy now what? Dr Richard Perry Imperial College NHS Trust Imperial College Talk outline Recognising seizure types Management of status epilepticus Some definitions Epileptic seizure A clinical
More informationTRANSPARENCY COMMITTEE OPINION. 19 July 2006
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 19 July 2006 Keppra 250 mg, film-coated tablets Box of 60 tablets (CIP code: 356 013-6) Keppra 500 mg, film-coated
More informationEPILEPSY DIAGNOSIS. Investigations- EEG, MRI, CT, blood tests. Appendix 1 contains a guide to questions to help with diagnosis
EPILEPSY DIAGNOSIS All adults with a recent-onset suspected seizure should be seen urgently by a specialist. The seizure type(s) and epilepsy syndrome, aetiology and co-morbidity should be determined.
More informationStatus Epilepticus in Children
PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Status Epilepticus in Children. These podcasts are designed to give medical students an overview of key topics in pediatrics.
More informationRefractory Seizures. Dr James Edwards EMCORE May 30th 2014
Refractory Seizures Dr James Edwards EMCORE May 30th 2014 Refractory Seizures Seizures are a common presentation to the ED and some patients will have multiple seizures or have a reduced level of consciousness
More informationShared Care Guideline. The Management of Epilepsies in Children
THE SOUTH YORKSHIRE & BASSETLAW Shared Care Guideline For The Management of Epilepsies in Children Shared care guideline developed by: Sheffield Children's NHS Foundation Trust; Dr P Baxter Consultant
More informationEpilepsy the Essentials
INSTITUTE OF NEUROLOGY DCEE / NSE Epilepsy the Essentials Fergus Rugg-Gunn Consultant Neurologist Dept of Clinical and Experimental Epilepsy Institute of Neurology, University College London Epilepsy Society
More informationFebrile seizures. Olivier Dulac. Hôpital Necker-Enfants Malades, Université Paris V, INSERM U663
Febrile seizures Olivier Dulac Hôpital Necker-Enfants Malades, Université Paris V, INSERM U663 olivier.dulac@nck.aphp.fr Definition Seizures precipitated by fever that is not due to an intracranial infection
More informationPRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT
PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,
More informationEpilepsy: pharmacological treatment by seizure type. Clinical audit tool. Implementing NICE guidance
Epilepsy: pharmacological treatment by seizure type Clinical audit tool Implementing NICE guidance 2012 NICE clinical guideline 137 Clinical audit tool: Epilepsy (2012) Page 1 of 25 This clinical audit
More informationOpinion 24 July 2013
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 24 July 2013 FYCOMPA 2 mg, film-coated tablet B/7 (CIP: 34009 267 760 0 8) B/28 (CIP: 34009 268 447 4 5) FYCOMPA 4
More informationTHE TREATMENT GAP AND POSSIBLE THERAPIES OF EPILEPSY IN SUB- SAHARAN AFRICA
THE TREATMENT GAP AND POSSIBLE THERAPIES OF EPILEPSY IN SUB- SAHARAN AFRICA DR A.O. CHARWAY-FELLI, MD, PhD NEUROLOGIST 37 MILITARY HOSPITAL, ACCRA, GHANA SECRETARY-GENERAL AFRICAN ACADEMY OF NEUROLOGY
More informationAnti-epileptic drugs: a guide for the non-neurologist
OCCASIONAL PAPERS Clinical Medicine 2010, Vol 10, No 1: 54 8 Anti-epileptic drugs: a guide for the non-neurologist Joseph Anderson and Carl-Christian Moor ABSTRACT Epilepsy is the most common serious chronic
More informationSurveillance report Published: 12 April 2018 nice.org.uk
Surveillance report 2018 Epilepsies: diagnosis and management (2012) NICE guideline CG137 Surveillance report Published: 12 April 2018 nice.org.uk NICE 2018. All rights reserved. Subject to Notice of rights
More informationChapter 15. Seizures. Learning Objectives. Learning Objectives 9/11/2012
Chapter 15 Seizures Learning Objectives Demonstrate proper procedure for rectal administration of diazepam, and discuss why rectal administration is sometimes necessary for patient having a seizure Discuss
More informationAlotaibi, Khalid Nijr (2017) Convulsive status epilepticus in children. PhD thesis, University of Nottingham.
Alotaibi, Khalid Nijr (2017) Convulsive status epilepticus in children. PhD thesis, University of Nottingham. Access from the University of Nottingham repository: http://eprints.nottingham.ac.uk/38829/1/khalid%20final%20thesis%20nov%202016.pdf
More informationIntroduction to seizure and epilepsy
Introduction to seizure and epilepsy 1 Epilepsy : disorder of brain function characterized by a periodic and unpredictable occurrence of seizures. Seizure : abnormal increased electrical activity in the
More informationRefractory Status Epilepticus in Children: What are the Options?
Refractory Status Epilepticus in Children: What are the Options? Weng Man Lam, PharmD, BCPS, BCPPS PICU Clinical Pharmacy Specialist Memorial Hermann Texas Medical Center November 11, 2017 Objectives 1.
More informationNMDOH digital library; keywords searched: pre-hospital, benzodiazepine, emergency medical technician, treatment of seizures, status epilepticus.
Background Literature Review and Recommendations Administration of Benzodiazepines by EMT -I in the pre-hospital setting EMS Bureau Protocol Review Steering Committee Status epilepticus is a recognized
More informationObjectives / Learning Targets: The learner who successfully completes this lesson will be able to demonstrate understanding of the following concepts:
Boone County Fire District EMS Education-Paramedic Program EMS 270 Medical Cases-Seizures Resources Seizures screencast Seizures Flowchart and Seizures Flowchart Video Explanation Objectives / Learning
More informationUnit VIII Problem 7 Pharmacology: Principles of Management of Seizure Disorders
Unit VIII Problem 7 Pharmacology: Principles of Management of Seizure Disorders - Terminologies: Anti-convulsants: they are used to control convulsions seen in certain types of epilepsy. Convulsions may
More informationLacosamide (Vimpat) for partial-onset epilepsy monotherapy. December 2011
Lacosamide (Vimpat) for partial-onset epilepsy monotherapy This technology summary is based on information available at the time of research and a limited literature search. It is not intended to be a
More informationUse of Subcutaneous Levetiracetam at the end of life:
Use of Subcutaneous Levetiracetam at the end of life: a literature review and audit Dr Anna Sutherland ST4 Palliative Medicine On behalf of the Health Education Thames Valley Registrars Research Network
More informationCrackCast Episode 18 Seizures
CrackCast Episode 18 Seizures Episode overview: 1) Define status epilepticus 2) List the doses of common medications used for status epilepticus 3) List 10 differential diagnoses for seizures 4) List 10
More informationEpilepsy is the tendency to have repeated seizures that originate in the brain.
Epilepsy Epilepsy - G40.9 (Clinical term: Epilepsy F25) Presenting complaints Usual presentation is sudden collapse associated with loss of consciousness and a convulsion. A range of phenomena may also
More informationScottish Medicines Consortium
Scottish Medicines Consortium levetiracetam, 250, 500, 750 and 1000mg tablets and levetiracetam oral solution 100mg/ml (Keppra ) No. (394/07) UCB Pharma Limited 10 August 2007 The Scottish Medicines Consortium
More informationEpilepsy 101. Overview of Treatment Kathryn A. O Hara RN. American Epilepsy Society
Epilepsy 101 Overview of Treatment Kathryn A. O Hara RN American Epilepsy Society Objectives Describe the main treatment options for epilepsy Identify factors essential in the selection of appropriate
More informationFirst aid for seizures
First aid for seizures What is epilepsy? Epilepsy is a tendency to have repeated seizures that begin in the brain. For most people with epilepsy their seizures will be controlled by medication. Around
More information1/31/2009. Paroxysmal, uncontrolled electrical discharge of neurons in brain interrupting normal function
Paroxysmal, uncontrolled electrical discharge of neurons in brain interrupting normal function In epilepsy abnormal neurons undergo spontaneous firing Cause of abnormal firing is unclear Firing spreads
More informationA. Incorrect! Seizures are not typically linked to alcohol use. B. Incorrect! Epilepsy is a seizure that is commonly associated with convulsions.
Pharmacology - Problem Drill 17: Central Nervous System Depressants Question No. 1 of 10 Instructions: (1) Read the problem statement and answer choices carefully (2) Work the problems on paper as 1. occur(s)
More informationAntiepileptic agents
Antiepileptic agents Excessive excitability of neurons in the CNS Abnormal function of ion channels Spread through neural networks Abnormal neural activity leads to abnormal motor activity Suppression
More informationTypes of epilepsy. 1)Generalized type: seizure activity involve the whole brain, it is divided into:
Types of epilepsy We have different types of epilepsy, so it is not one type of seizures that the patient can suffer from; we can find some patients with generalized or partial seizure. So, there are two
More informationIntroduction. 1 person in 20 will have an epileptic seizure at some time in their life
Introduction 1 person in 20 will have an epileptic seizure at some time in their life Epilepsy is diagnosed on the basis of two or more epileptic seizures. Around 450,000 people in the UK have epilepsy
More informationUse of Subcutaneous Levetiracetam at the end of life:
Use of Subcutaneous Levetiracetam at the end of life: a literature review and audit Dr Victoria Bradley ST4 Palliative Medicine On behalf of the Health Education Thames Valley Registrars Research Network
More information2018 American Academy of Neurology
Practice Guideline Update Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment-Resistant Epilepsy Report by: Guideline Development, Dissemination, and Implementation Subcommittee of the
More informationErnie Somerville Prince of Wales Hospital EPILEPSY
Ernie Somerville Prince of Wales Hospital EPILEPSY Overview Classification New and old anti-epileptic drugs (AEDs) Neuropsychiatric side-effects Limbic encephalitis Non-drug therapies Therapeutic wishlist
More informationAdult Seizure and Epilepsy Management Pathway (16 years of age and above)
Adult Seizure and Epilepsy Management Pathway (16 years of age and above) SUSPECTED SEIZURE Secure and record eyewitness account if available ECG Abnormal ECG Cardiac cause clinically possible Epilepsy
More informationCLINICIAN INTERVIEW AS i M: When you examine a clinical trial in new- onset epilepsy, how relevant are the results to your daily clinical practice?
FROM CLINICAL TRIALS TO CLINICAL PRACTICE: TRANSLATING EPILEPSY RESEARCH INTO PATIENT CARE Interview with Jacqueline A. French, MD Dr Jacqueline A. French is a Professor in the Department of Neurology
More informationComplex Care Hub Manual: Caring for a Child with Epilepsy/Seizures
Complex Care Hub Manual: Caring for a Child with Epilepsy/Seizures Table of Contents Complex Care Hub Manual: Caring for a Child with Epilepsy/Seizures 1 1. What is epilepsy?... 2 2. Causes of epilepsy...
More informationCare in the Last Days of Life
Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient
More informationFEBRILE SEIZURES. IAP UG Teaching slides
FEBRILE SEIZURES 1 DEFINITION Febrile seizures are seizures that occur between the age of 6 and 60 months with a temperature of 38 C or higher, that are not the result of central nervous system infection
More informationAPPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline
Drug name APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline Unit costs and weighted average unit costs for drug used in the treatment of focal and generalised epilepsies Prescription Cost
More informationNewcastle Mitochondrial Disease Guidelines
Newcastle Mitochondrial Disease Guidelines Epilepsy in Adult Mitochondrial Disease: Investigation and Management First published August 2010 Updated January 2013 1 Contents Introduction 3 Patient Centered
More informationNATIONAL INSTITUTE FOR CLINICAL EXCELLENCE. Final Appraisal Determination. Newer drugs for epilepsy in children
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guidance 1.1 The newer antiepileptic drugs gabapentin, lamotrigine, oxcarbazepine, tiagabine, topiramate, and vigabatrin (as an adjunctive therapy for partial
More informationEpilepsy. Seizures and Epilepsy. Buccal Midazolam vs. Rectal Diazepam for Serial Seizures. Epilepsy and Seizures 6/18/2008
Seizures and Epilepsy Paul Garcia, M.D. UCSF Epilepsy Epileptic seizure: the physical manifestation of aberrant firing of brain cells Epilepsy: the tendency to recurrent, unprovoked epileptic seizures
More informationNEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES
NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES GENERAL PRINCIPLES Neuropathic pain may be relieved in the majority of patients by multimodal management A careful history and examination are essential.
More informationNewer drugs for epilepsy in children
NHS National Institute for Clinical Excellence Newer drugs for epilepsy in children Technology Appraisal 79 April 2004 Technology Appraisal Guidance 79 Newer drugs for epilepsy in children Issue date:
More informationPain Rating Scale GG. PAIN MANAGEMENT (NEW 10) 1. Initiate General Patient Care.
GG. PAIN MANAGEMENT (NEW 10) 1. Initiate General Patient Care. 2. Presentation Pain may be present in many different conditions. Management of pain in the field can help to reduce suffering, make transport
More informationUse of Subcutaneous Levetiracetam at the end of life:
Use of Subcutaneous Levetiracetam at the end of life: a literature review and audit Dr Victoria Bradley ST4 Palliative Medicine On behalf of the Health Education Thames Valley Registrars Research Network
More informationSeizures Emergency Treatment
Seizures Emergency Treatment Emergency Seizures SEIZURE CLASSIFICATION Cluster seizures - 2 or more generalized convulsive seizures in 24 hours Simon R. Platt BVM&S MRCVS Dipl. ACVIM (Neurology) Dipl.ECVN
More informationEpilepsy / Seizures EPI
Epilepsy / Seizures EPI Epilepsy is a chronic condition, characterized by recurrent unprovoked seizures. It has several causes; it may be genetic or may occur in people who have a past history of birth
More informationStatus Epilepticus. Ednea Simon, MD Swedish Pediatric Neuroscience Center
Status Epilepticus Ednea Simon, MD Swedish Pediatric Neuroscience Center 1 Status Epilepticus Status epilepticus (SE) is a condition resulting either from failure of the mechanisms responsible for seizure
More informationAntiepileptics. Medications Comment Quantity Limit Carbamazepine. May be subject Preferred to quantity limit Epitol
Market DC Antiepileptics Override(s) Approval Duration Prior Authorization 1 year Step Therapy Quantity Limit *Indiana Medicaid See State Specific Mandate below *Maryland Medicaid See State Specific Mandate
More informationEpilepsy T.I.A. Cataplexy. Nonepileptic seizure. syncope. Dystonia. Epilepsy & other attack disorders Overview
: Clinical presentation and management Markus Reuber Professor of Clinical Neurology Academic Neurology Unit University of Sheffield, Royal Hallamshire Hospital. Is it epilepsy? Overview Common attack
More informationRescue medications. What are rescue medications? Ideal rescue medication. Why use rescue medications?
Rescue medications Out-of-hospital treatment of prolonged seizures or acute repetitive seizures What are rescue medications? Medicines used to terminate a prolonged seizure or acute repetitive seizures
More informationOverview. 5% of paeds a+endances to ED
Seizures Overview 5% of paeds a+endances to ED Status Epilepticus generalised convulsions las7ng 30 minutes or longer or failed to regain consciousness between fits over 30 minutes Why is SE important?
More informationDisclosures. What is Status Epilepticus? Purpose of Today s Discussion. Nothing to Disclose. How do I recognize Status Epilepticus?
Disclosures Nothing to Disclose Neurologic Emergencies SID W. ATKINSON MD Chief, Division of Child Neurology, and Developmental Pediatrics Purpose of Today s Discussion Understand 2 Neurologic Emergencies
More informationSymptoms and problems in the End of Life Phase of High Grade Glioma Patients
Chapter 2.1 Symptoms and problems in the End of Life Phase of High Grade Glioma Patients Eefje M. Sizoo Lies Braam Tjeerd J. Postma H. Roeline W. Pasman Jan J. Heimans Martin Klein Jaap C. Reijneveld Martin
More informationKeywords: treatment; epilepsy; population based cohort Institute of Neurology, University College London, London WC1N 3BG, UK
632 Institute of Neurology, University College London, London WC1N 3BG, UK S D Lhatoo JWASSander S D Shorvon Correspondence to: Professor J W Sander, Department of Clinical and Experimental Epilepsy, Institute
More information11/7/2018 EPILEPSY UPDATE. Dr.Ram Sankaraneni. Disclosures. Speaker bureau LivaNova
EPILEPSY UPDATE Dr.Ram Sankaraneni Disclosures Speaker bureau LivaNova 1 Outline New onset Seizure Investigations in patients with epilepsy Medical management of epilepsy Non Pharmacological options in
More informationManagement of Complex Febrile Seizures
Management of Complex Febrile Seizures An 13 month old girl presents to the ED after having a shaking episode at home. Mom describes shaking of both arms and legs, lasting 20 minutes. The child has no
More informationFirst Line Therapy in Acute Seizure Management. William Dalsey, MD, FACEP
First Line Therapy in Acute Seizure Management Case Presentation A 32-year old male intravenous drug user was brought to the ED having had a witnessed generalized tonic-clonic seizure 10 minutes prior
More informationAppendix M Health Economic Evidence Extractions
Appendix M Health Economic Evidence Extractions Which AEDs are clinically effective and cost-effective for people with focal epilepsy with or without secondary generalisation seizures? Frew E, Sandercock
More informationTITLE: Pharmacological Treatments in Patients with Epilepsy: Guidelines
TITLE: Pharmacological Treatments in Patients with Epilepsy: Guidelines DATE: 01 April 2011 RESEARCH QUESTION What are the evidence-based guidelines for pharmacological treatments in patients with epilepsy?
More informationSeizure Management in End-of-Life Care: Fit for the Future? DR NICKY HARRIS PALLIATIVE CARE PAEDIATRICIAN PHD CANDIDATE, UWE
Seizure Management in End-of-Life Care: Fit for the Future? DR NICKY HARRIS PALLIATIVE CARE PAEDIATRICIAN PHD CANDIDATE, UWE Seizure/Fits/Convulsions Common in children with Life-limiting illness Neurological
More informationManagement of Seizures at the End of Life A new way forward?
Management of Seizures at the End of Life A new way forward? Dr Victoria Bradley ST4 Palliative Medicine On behalf of the Health Education Thames Valley Registrars Research Network Dr Anna Sutherland,
More informationGeneric Name (Brand Name) Available Strengths Formulary Limits. Primidone (Mysoline) 50mg, 250mg -- $
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Epilepsy P&T DATE: 2/15/2017 THERAPEUTIC CLASS: Neurologic Disorders REVIEW HISTORY: 2/16 LOB AFFECTED: Medi-Cal (MONTH/YEAR)
More information